[DPHARMA] YoY TTM Result on 31-Mar-2024 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
23-May-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
31-Mar-2024 [#1]
Profit Trend
QoQ- -13.97%
YoY- -37.49%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 697,220 711,251 658,662 577,643 584,789 515,849 477,940 6.48%
PBT 55,077 86,497 86,454 81,606 69,750 65,197 52,929 0.66%
Tax -9,787 -14,043 -18,094 -18,943 -15,381 -13,738 -9,746 0.06%
NP 45,290 72,454 68,360 62,663 54,369 51,459 43,183 0.79%
-
NP to SH 45,290 72,454 68,360 62,663 54,369 51,459 43,710 0.59%
-
Tax Rate 17.77% 16.24% 20.93% 23.21% 22.05% 21.07% 18.41% -
Total Cost 651,930 638,797 590,302 514,980 530,420 464,390 434,757 6.97%
-
Net Worth 682,979 666,567 621,987 635,424 540,662 496,410 206,429 22.04%
Dividend
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Div 22,103 21,874 20,482 45,783 40,733 30,674 23,711 -1.16%
Div Payout % 48.81% 30.19% 29.96% 73.06% 74.92% 59.61% 54.25% -
Equity
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Net Worth 682,979 666,567 621,987 635,424 540,662 496,410 206,429 22.04%
NOSH 961,942 952,239 941,765 706,026 684,383 661,881 278,959 22.89%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 6.50% 10.19% 10.38% 10.85% 9.30% 9.98% 9.04% -
ROE 6.63% 10.87% 10.99% 9.86% 10.06% 10.37% 21.17% -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
RPS 72.48 74.69 70.95 81.82 85.45 77.94 171.33 -13.34%
EPS 4.71 7.61 7.36 8.88 7.94 7.77 15.67 -18.14%
DPS 2.30 2.30 2.21 6.48 5.95 4.63 8.50 -19.56%
NAPS 0.71 0.70 0.67 0.90 0.79 0.75 0.74 -0.68%
Adjusted Per Share Value based on latest NOSH - 961,942
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
RPS 72.48 73.94 68.47 60.05 60.79 53.63 49.68 6.49%
EPS 4.71 7.53 7.11 6.51 5.65 5.35 4.54 0.61%
DPS 2.30 2.27 2.13 4.76 4.23 3.19 2.46 -1.11%
NAPS 0.71 0.6929 0.6466 0.6606 0.5621 0.5161 0.2146 22.04%
Price Multiplier on Financial Quarter End Date
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Date 29/03/24 31/03/23 31/03/22 31/03/21 31/03/20 29/03/19 30/03/18 -
Price 1.20 1.56 1.49 2.75 1.39 1.28 2.80 -
P/RPS 1.66 2.09 2.10 3.36 1.63 1.64 1.63 0.30%
P/EPS 25.49 20.50 20.23 30.98 17.50 16.46 17.87 6.09%
EY 3.92 4.88 4.94 3.23 5.72 6.07 5.60 -5.76%
DY 1.92 1.47 1.48 2.36 4.28 3.62 3.04 -7.36%
P/NAPS 1.69 2.23 2.22 3.06 1.76 1.71 3.78 -12.54%
Price Multiplier on Announcement Date
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Date 23/05/24 22/05/23 17/05/22 03/05/21 18/05/20 21/05/19 28/05/18 -
Price 1.26 1.44 1.51 2.93 1.72 1.36 3.35 -
P/RPS 1.74 1.93 2.13 3.58 2.01 1.75 1.96 -1.96%
P/EPS 26.76 18.93 20.51 33.01 21.65 17.49 21.38 3.80%
EY 3.74 5.28 4.88 3.03 4.62 5.72 4.68 -3.66%
DY 1.83 1.60 1.46 2.21 3.46 3.41 2.54 -5.31%
P/NAPS 1.77 2.06 2.25 3.26 2.18 1.81 4.53 -14.48%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment